Richard Stark 4
4 · ANGIODYNAMICS INC · Filed Jul 28, 2017
Insider Transaction Report
Form 4
Richard Stark
SVP, GM - Oncology
Transactions
- Tax Payment
Common Stock
2017-07-25$17.12/sh−432$7,396→ 17,608 total - Tax Payment
Common Stock
2017-07-22$16.80/sh−393$6,602→ 18,040 total - Award
Performance Right
2017-07-26+7,296→ 7,296 total→ Common Stock (7,296 underlying) - Award
Common Stock
2017-07-26+3,648→ 21,256 total - Award
Non-Qualified Stock Option (right to buy)
2017-07-26+12,818→ 12,818 totalExercise: $16.55From: 2018-07-26Exp: 2027-07-26→ Common Stock (12,818 underlying)
Footnotes (5)
- [F1]The exempt disposition of 393 shares of common stock ("Common Stock") of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 22, 2015.
- [F2]The exempt disposition of 432 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 25, 2014.
- [F3]This acquisition of 3,648 shares of Common Stock represents 3,648 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 26, 2018, such that 25% of the restricted stock units will vest on each of July 26, 2018, 2019, 2020 and 2021.
- [F4]These stock options vest in four equal annual installments beginning on July 26, 2018, such that 25% of the options will vest on each of July 26, 2018, 2019, 2020 and 2021.
- [F5]Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited.